article thumbnail

Community Pharmacies and Harm Reduction

Common Sense for Drug Policy Blog

Community Pharmacies and Harm Reduction "Community pharmacies are essential healthcare destinations that serve as an optimal resource for addressing non-urgent inquiries, such as safe injecting practices, management of adverse drug reactions, and medication provision, thus reducing the burden on general practitioners (GPs) [ 1 , 2 ].

article thumbnail

Community Pharmacies and Anabolic-Androgenic Steroid Consumers

Common Sense for Drug Policy Blog

Community Pharmacies and Anabolic-Androgenic Steroid Consumers "With the growing availability of AAS [Anabolic-Androgenic Steroids] through online platforms [ 71 , 72 ] the traditional reliance on social networks and healthcare providers for access to injecting equipment and safer use information has diminished [ 73 – 76 ].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

British consumers have increasingly turned to community pharmacies during COVID-19

The Pharma Data

British consumers have increasingly turned to community pharmacies during the coronavirus pandemic, according to a new study. It found 57% of UK consumers are looking to community pharmacists to provide advice about over-the-counter healthcare products. This rose to 68% in the 45-54 age bracket.

article thumbnail

World Suicide Prevention Day 2023: the Lifeguard Pharmacy study

On Medicine

The Lifeguard Pharmacy study tests whether a community pharmacy response service would offer a discreet and accessible help-seeking avenue for people experiencing suicidal ideation and/or domestic abuse. Project findings Lifeguard poster in the window of a pharmacy We trained 37 community pharmacy staff to be Lifeguards.

Pharmacy 105
article thumbnail

Buprenorphine now replaces methadone as the most common medicine for opioid dependence’: 10-year trends in opioid agonist treatment medicines in Australia

National Drug & Alcohol Research Centre Blog

The use of opioid agonist treatment increased in non-community pharmacy settings from early 2020. Increases were seen for buprenorphine. However, the number of client-months on methadone over the study period remained relatively stable. This increase was particularly evident in drug and alcohol outpatient clinics and prisons.

Treatment 133
article thumbnail

Childhood trauma associated with increased risk of opioid use disorder (OUD) among people prescribed opioids for chronic non-cancer pain.

National Drug & Alcohol Research Centre Blog

Using data from 1514 people prescribed opioids long-term (median 4 years) for CNCP recruited from community pharmacies across Australia, five indicators of childhood trauma exposure were characterised. This type of e xposure is associated with neurobiological and psychosocial harm that may continue through adulthood.

article thumbnail

AHF Cheers Supreme Court ‘Rutledge’ Ruling Allowing States to Regulate PBMs

The Pharma Data

(See SCOTUS ‘Rutledge’ ruling ) PBMs sit between healthcare plans and pharmacies – they are the bridge that connects pharmacies to health plans, adjudicates pharmacy claims and administers the pharmacy network for the plans.